SCHEMBL2880255

SCHEMBL2880255

O=C(O)c1cccnc1-c1cc2ccccc2s1.O=C(O)c1cccnc1-c1cc2ccccc2s1.O=C(O)c1cccnc1-c1cc2ccccc2s1.[Ir]

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.54
TDP1 Q9NUW8 1/20 0.54
CA12 O43570 1/20 0.50
CA1 P00915 1/20 0.50
CA2 P00918 1/20 0.50
CA4 P22748 1/20 0.50
CA5A P35218 1/20 0.50
CA7 P43166 1/20 0.50
CA9 Q16790 1/20 0.50
CA14 Q9ULX7 1/20 0.50
CA5B Q9Y2D0 1/20 0.50
BCL2L1 Q07817 1/20 0.46
IKBKB O14920 4/20 0.46
CYP19A1 P11511 1/20 0.46
CHUK O15111 1/20 0.46
IKBKG Q9Y6K9 1/20 0.46
ALDH1A1 P00352 2/20 0.43
PLAU P00749 1/20 0.43
LMNA P02545 1/20 0.43
ALOX12 P18054 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2877899 0.99 KDM4E (0.56) KDM4ETDP1CA12CA1CA2
SCHEMBL31661936 0.86 IKBKB (0.52) CA12CA1CA2CA4CA5A
SCHEMBL2880254 0.85 IKBKB (0.42) KDM4ETDP1CA12CA1CA2
SCHEMBL29177680 0.78 CYP19A1 (0.48) CA1CA2CA9IKBKBCYP19A1
SCHEMBL28537163 0.76 IKBKB (0.40) BCL2L1IKBKBCYP19A1CHUKIKBKG
SCHEMBL17799582 0.76 CA12 (0.58) CA12CA1CA2CA4CA5A
SCHEMBL15260648 0.76 CYP19A1 (0.49) CA1CA2CA9IKBKBCYP19A1
SCHEMBL29986368 0.75 CYP19A1 (0.48) IKBKBCYP19A1PLAUAPP
SCHEMBL28401036 0.75 CYP19A1 (0.48) CA1CA2CA9IKBKBCYP19A1
SCHEMBL15025442 0.74 CA1 (0.60) CA12CA1CA2CA4CA5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8420231-B2 Iridium phosphorescent dendrimer, method of preparing the same and electroluminescent device including the iridium phosphorescent dendrimer SAMSUNG ELECTRONICS CO., LTD. (KR) 2013-04-16 US claimed
US-20100084970-A1 IRIDIUM PHOSPHORESCENT DENDRIMER, METHOD OF PREPARING THE SAME AND ELECTROLUMINESCENT DEVICE INCLUDING THE IRIDIUM PHOSPHORESCENT DENDRIMER SAMSUNG ELECTRONICS CO., LTD (KR) 2010-04-08 US claimed
US-8420231-B2 Iridium phosphorescent dendrimer, method of preparing the same and electroluminescent device including the iridium phosphorescent dendrimer SAMSUNG ELECTRONICS CO., LTD. (KR) 2013-04-16 US disclosed
US-20100084970-A1 IRIDIUM PHOSPHORESCENT DENDRIMER, METHOD OF PREPARING THE SAME AND ELECTROLUMINESCENT DEVICE INCLUDING THE IRIDIUM PHOSPHORESCENT DENDRIMER SAMSUNG ELECTRONICS CO., LTD (KR) 2010-04-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100084970-A1 IRIDIUM PHOSPHORESCENT DENDRIMER, METHOD OF PREPARING THE SAME AND ELECTROLUMINESCENT DEVICE INCLUDING THE IRIDIUM PHOSPHORESCENT DENDRIMER DNM1, FIS1, DCUN1D1 KDM4E 4672/4885TDP1 977/4885CA12 3661/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.